Skip to content

Use Of Nimba Kshar Pratisaran In Abhyantar Arsha

Randomized Controlled Clinical Trial To Evaluate The Efficacy Of Nimba Kshar Pratisaran In The Management Of Abhayantar Arsha wsr To 2Nd & 3Rd Degree Internal Haemorrhoids - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108857
Enrollment
74
Registered
2026-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K64- Hemorrhoids and perianal venous thrombosis

Interventions

None listed

Sponsors

Dr Onkar Kumar Kale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with classical signs and symptoms of arsha. Patients between age group of 20 to 60 years. Patients of Internal Haemorrhoids of all position with second ajd third degree of Internal Haemorrhoids. Selection of patient will be done irrespective of sex, socioeconomic class, religion.

Exclusion criteria

Exclusion criteria: 4th degree prolapsed Internal Haemorrhoids. Thrombosed Haemorrhoids. Pregnancy and lactating women. Other anorectal conditions with Haemorrhoids for eg Fissure Fistula In ano. Patient suffering from haemorrhoids with kco malignancy Ulcerative Colitis crohns disease liver disorder and other chronic disease like anemia. Uncontrolled systemic disorders like kco HTN DM Asthama CVS disorders.

Design outcomes

Primary

MeasureTime frame
To study the efficacy of Nimba kshar Pratisaran in Abhyantar Arsha wsr 2nd and 3rd degree Internal Haemorrhoids.Timepoint: 21 days

Secondary

MeasureTime frame
To measure the reduction in associated symptoms of Abhyantar Arsha (2nd & 3rd degree internal haemorrhoids) after 21 days of treatment with Nimba Kshar Pratisaran. To assess improvement based on signs symptoms and gradation of assessment criteria. To improve quality of life and reduce patient discomfort. To evaluate the overall outcome of the study at the end of 21 days.Timepoint: 21 days

Countries

India

Contacts

Public ContactDr Onkar Kumar Kale

Matoshri Asarabai Darade Ayurved College and Hospital Babhulagaon Yeola Dist Nashik

manojsonaje@gmail.com9423932283

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026